Skip to main content

Advertisement

SpringerLink
Log in

A statistical study on malignant melanoma over the past 12 years in Fukui University Hospital

  • Original Article
  • Published:
International Journal of Clinical Oncology Aims and scope Submit manuscript

Abstract

Background

The survival rate of patients with malignant melanoma is still low, and there is no established chemotherapeutic method. With the appearance of molecular targeted drugs, improvement in the survival rate can be expected. However, at present, malignant melanoma remains a disease associated with one of the poorest prognoses.

Materials and methods

We analyzed a total of 51 cases of malignant melanoma who were treated at the Department of Dermatology, University of Fukui from September 2001 to May 2013.

Results

The survival rate was significantly lower in patients aged ≥65 years. The 5-year survival rate was 100 % for Stage 0/I, 79.59 % for Stage II, and 52 % for Stage III. The incidence of lymph node metastasis was highest in nodular melanoma, and zero in lentigo maligna melanoma. There was a significantly high risk of lymph node metastasis in the presence of ulceration. There was no association between incisional biopsy and lymph node metastasis.

Conclusions

Although the data were obtained in only one institution and the number of cases was limited in this study, the results are close to previous international data.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10

Similar content being viewed by others

References

  1. Ishihara K, Saida T, Otsuka F et al (2008) Statistical profiles of malignant melanoma and other skin cancers in Japan: 2007 update. Int J Clin Oncol 13(1):33–41

    Article  PubMed  Google Scholar 

  2. Ishihara K, Saida T, Yamazaki N et al (2009) Statistical analysis of malignant melanoma: clinical features and therapeutic survival rate in terms of patients’ age difference (in Japanese). Skin Cancer (Japan) 24(2):258–266

    Article  Google Scholar 

  3. Kurooka S, Namikawa K, Tsutsumida A et al (2012) 2002–2007 nen no touka ni okeru hihugenpatsuakuseikokushokushu no toukei (in Japanese) [A statistical study of malignant skin melanoma between 2002-2007 in our institution]. Hihu byo shinryo (Japan) 34(5):506–511

    Google Scholar 

  4. Fujisawa Y, Otsuka F, Yamamoto A et al (2012) Statistics of melanoma in Japan: analysis of a 2006–2007 nationwide survey and a 2005–2010 follow-up survey (in Japanese). Skin Cancer (Japan) 27(2):195–204

    Article  Google Scholar 

  5. Ishihara K (2006) Statistics and prognostic factors for malignant skin tumors in Japan: malignant melanoma (in Japanese). Skin Cancer (Japan) 20(3):234–248

    Article  Google Scholar 

  6. Chi Z, Li S, Sheng X et al (2011) Clinical presentation, histology, and prognoses of malignant melanoma in ethnic Chinese: a study of 522 consecutive cases. BMC Cancer 11:85

    Article  PubMed Central  PubMed  Google Scholar 

  7. Kumano K (2012) 2010 malignant melanoma group study report. Japan J Derm Surg (Japan) 16(2):156–157 (in Japanese)

    Google Scholar 

  8. Thompson JF, Soong SJ, Balch CM et al (2011) Prognostic significance of mitotic rate in localized primary cutaneous melanoma: an analysis of patients in the multi-institutional American joint committee on cancer melanoma staging database. J Clin Oncol 29(16):2199–2205

    Article  PubMed Central  PubMed  Google Scholar 

  9. Pawlik TM, Ross MI, Johnson MM et al (2005) Predictors and natural history of in-transit melanoma after sentinel lymphadenectomy. Ann Surg Oncol 12(8):587–596

    Article  PubMed  Google Scholar 

  10. Cascinelli N, Bufalino R, Marolda R et al (1986) Regional non-nodal metastases of cutaneous melanoma. Eur J Surg Oncol 12(2):175–180

    CAS  PubMed  Google Scholar 

  11. Kretschmer L, Beckmann I, Thoms KM et al (2006) Factors predicting the risk of in-transit recurrence after sentinel lymphonodectomy in patients with cutaneous malignant melanoma. Ann Surg Oncol 13(8):1105–1112

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

  1. Division of Plastic and Reconstructive Surgery, Department of Dermatology, School of Medicine, University of Fukui, 23-3 Matsuoka-shimoaizuki, 910-1193, Fukui, Japan

    Masato Yasuta & Suguru Sato

  2. Sapporo Wound-Care and Anti-Aging Laboratory, Sapporo, Japan

    Sachio Kouraba

  3. Department of Dermatology, University of Fukui, Fukui, Japan

    Shiro Iino & Takahiro Kiyohara

Authors
  1. Masato Yasuta
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Suguru Sato
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sachio Kouraba
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Shiro Iino
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Takahiro Kiyohara
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Masato Yasuta.

About this article

Cite this article

Yasuta, M., Sato, S., Kouraba, S. et al. A statistical study on malignant melanoma over the past 12 years in Fukui University Hospital. Int J Clin Oncol 20, 182–187 (2015). https://doi.org/10.1007/s10147-014-0683-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10147-014-0683-5

Keywords

Search

Navigation